Exercise testing in respiratory medicine: DGP recommendations;Belastungsuntersuchungen in der pneumologie: Empfehlungen der deutschen gesellschaft für pneumologie und beatmungsmedizin e.v.

Pneumologie

Volumn 67, Issue 1, 2013, Pages 16-34

  Meyer, F J ^a   Borst, M M ^b   Buschmann, H C ^c   Ewert, R ^d   Friedmann Bette, B ^e   Ochmann, U ^f   Petermann, W ^c   Preisser, A M ^g   Rohde, D ^e   Ruhle K H ^h   Sorichter, S ⁱ   Stahler G ^j   Westhoff, M ^k   Worth, H ^l  

^a Klinik Für Hämatologie Onkologie und Palliativmedizin Klinikum Harlaching Städtisches Klinikum   (Germany)

^b CARITAS KRANKENHAUS   (Germany)

^c Bruderkrankenhaus St Josef Paderborn   (Germany)

^d Universitatsmedizin   (Germany)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^g UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^h UNIVERSITY OF WITTEN HERDECKE   (Germany)

ⁱ UNIVERSITY OF FREIBURG   (Germany)

^j Klinik Lowenstein   (Germany)

^k Sozialpsychiatrie und Psychotherapie   (Germany)

^l KLINIKUM FÜRTH   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIAL GAS; ARTICLE; ASTHMA; CONSENSUS DEVELOPMENT; EXERCISE TEST; HEART CATHETERIZATION; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SPIROMETRY; STRESS ECHOCARDIOGRAPHY; WALKING; GERMANY; HEART FUNCTION TEST; LUNG FUNCTION TEST; PRACTICE GUIDELINE; PULMONOLOGY; STANDARDS; STANDARD;

EXERCISE TEST; GERMANY; HEART FUNCTION TESTS; PRACTICE GUIDELINES AS TOPIC; PULMONARY MEDICINE; RESPIRATORY FUNCTION TESTS; SPIROMETRY;

EID: 84872182008     PISSN: 09348387     EISSN: 14388790     Source Type: Journal    
DOI: 10.1055/s-0032-1325901     Document Type: Article

References (265)

1. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med: 2003; 167 211 277
2. Palange P., Ward S. A., Carlsen K. H. et al. Recommendations on the use of exercise testing in clinical practice. Eur Respir J: 2007; 29 185 209
3. Balady G. J., Arena R., Sietsema K. et al. Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation: 2010; 122 191 225
4. Worth H., Breuer H-W et al. Deutsche Gesellschaft für Pneumologie: Empfehlungen zur Durchführung und Bewertung von Belastungsuntersuchungen in der Pneumologie. Pneumologie: 1998; 52 225 231
5. Magnussen H., Kirsten A. M., Kohler D. et al. [Guidelines for long-term oxygen therapy. German Society for Pneumology and Respiratory Medicine]. Pneumologie: 2008; 62 748 756
6. Keteyian S. J., Isaac D., Thadani U. et al. Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Am Heart J: 2009; 158 S72 S77
7. Gibbons R. J., Balady G. J., Bricker J. T. et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation: 2002; 106 1883 1892
8. Miyamura M., Honda Y. Oxygen intake and cardiac output during maximal treadmill and bicycle exercise. J Appl Physiol: 1972; 32 185 188
9. Christensen C. C., Ryg M. S., Edvardsen A. et al. Effect of exercise mode on oxygen uptake and blood gases in COPD patients. Respir Med: 2004; 98 656 660
10. Buchfuhrer M. J., Hansen J. E., Robinson T. E. et al. Optimizing the exercise protocol for cardiopulmonary assessment. J Appl Physiol: 1983; 55 1558 1564
11. Hsia D., Casaburi R., Pradhan A. et al. Physiological responses to linear treadmill and cycle ergometer exercise in COPD. Eur Respir J: 2009; 34 605 615
12. Mathur R. S., Revill S. M., Vara D. D. et al. Comparison of peak oxygen consumption during cycle and treadmill exercise in severe chronic obstructive pulmonary disease. Thorax: 1995; 50 829 833
13. Bonzheim S. C., Franklin B. A., DeWitt C. et al. Physiologic responses to recumbent versus upright cycle ergometry, and implications for exercise prescription in patients with coronary artery disease. Am J Cardiol: 1992; 69 40 44
14. Hughes J. MB. Physiology and practice of pulmonary function. West Midlands Association for respiratory technology and physiology (ARTP): 2009
15. Löllgen H., Erdmann E., Gitt A. Ergometrie. 3. ed. Heidelberg Springer Verlag: 2011
16. Wasserman K., Hansen J. E., Sue D. Y. et al. Principles of Exercise Testing and Interpretation: Including Pathophysiology and Clinical Applications. 5. ed. Philadelphia Lippincott, Williams & Wilkins: 2011
17. Debigare R., Maltais F., Mallet M. et al. Influence of work rate incremental rate on the exercise responses in patients with COPD. Med Sci Sports Exerc: 2000; 32 1365 1368
18. Revill S. M., Beck K. E., Morgan M. D. Comparison of the peak exercise response measured by the ramp and 1-min step cycle exercise protocols in patients with exertional dyspnea. Chest: 2002; 121 1099 1105
19. Benzo R. P., Paramesh S., Patel S. A. et al. Optimal protocol selection for cardiopulmonary exercise testing in severe COPD. Chest: 2007; 132 1500 1505
20. Glaser S., Lodziewski S., Koch B. et al. Influence of the incremental step size in work rate on exercise response and gas exchange in patients with pulmonary hypertension. BMC Pulm Med: 2008; 8 3
21. Naughton J. P., Balke B., Nagle F. J. Refinements in methods of evaluation and physical conditioning before and after myocardial infarction. Am J Cardiol: 1964; 14 837 843
22. Bruce R. A., McDonough J. R. Stress testing in screening for cardiovascular disease. Bull N Y Acad Med: 1969; 45 1288 1305
23. American College of Sports Medicine ACSM' Guidelines for Exercise Testing and Prescription. Philadelphia Lippincott, Williams and Wilkins: 2010
24. Midgley A. W., Bentley D. J., Luttikholt H. et al. Challenging a dogma of exercise physiology: does an incremental exercise test for valid VO2max determination really need to last between 8 and 12 minutes? Sports Med: 2008; 38 441 447
25. Whipp B. J. Rate constant for the kinetics of oxygen uptake during light exercise. J Appl Physiol: 1971; 30 261 263
26. Nery L. E., Wasserman K., Andrews J. D. et al. Ventilatory and gas exchange kinetics during exercise in chronic airways obstruction. J Appl Physiol: 1982; 53 1594 1602
27. Oga T., Nishimura K., Tsukino M. et al. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease.A comparison of three different exercise tests. Am J Respir Crit Care Med: 2000; 161 1897 1901
28. Casaburi R., Porszasz J. Constant work rate exercise testing: a tricky measure of exercise tolerance. COPD: 2009; 6 317 319
29. Puente-Maestu L., Villar F., Miguel J. et al. Clinical relevance of constant power exercise duration changes in COPD. Eur Respir J: 2009; 34 340 345
30. Nagle F. J., Balke B., Naughton J. P. Gradational step tests for assessing work capacity. J Appl Physiol: 1965; 20 745 748
31. Naughton J. P., Hellerstein H. K., Haider R. Methods of exercise testing. Exercise testing and exercise training in coronary heart disease. New York Academic Press: 1973
32. Shephard R. J. Tests of maximum oxygen intake. A critical review. Sports Med: 1984; 1 99 124
33. Trappe H. J., Löllgen H. [Guidelines for ergometry. German Society of Cardiology - Heart and Cardiovascular Research]. Z Kardiol: 2000; 89 821 831
34. Koch B., Schaper C., Ittermann T. et al. Reference values for cardiopulmonary exercise testing in healthy volunteers: the SHIP study. Eur Respir J: 2009; 33 389 397
35. Glaser S., Koch B., Ittermann T. et al. Influence of age, sex, body size, smoking, and beta blockade on key gas exchange exercise parameters in an adult population. Eur J Cardiovasc Prev Rehabil: 2010; 17 469 476
36. Brown S. E., Fischer C. E., Stansbury D. W. et al. Reproducibility of VO2max in patients with chronic air-flow obstruction. Am Rev Respir Dis: 1985; 131 435 438
37. Marciniuk D. D., Watts R. E., Gallagher C. G. Reproducibility of incremental maximal cycle ergometer testing in patients with restrictive lung disease. Thorax: 1993; 48 894 898
38. Meyer K., Westbrook S., Schwaibold M. et al. Short-term reproducibility of cardiopulmonary measurements during exercise testing in patients with severe chronic heart failure. Am Heart J: 1997; 134 20 26
39. O'Donnell D. E., Travers J., Webb K. A. et al. Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD. Eur Respir J: 2009; 34 866 874
40. Hansen J. E., Sun X. G., Yasunobu Y. et al. Reproducibility of cardiopulmonary exercise measurements in patients with pulmonary arterial hypertension. Chest: 2004; 126 816 824
41. Andersen K. L., Shepard R. J., Denolin H. et al. Fundamentals of exercise testing. Geneva World Health Organisation: 1971; 138
42. Borg G. A. Psychophysical bases of perceived exertion. Med Sci Sports Exerc: 1982; 14 377 381
43. Borg G. Anstrengungsempfinden. Dt Aerztebl: 2004; 101 A1026 A1021
44. Ries A. L. Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD: 2005; 2 105 110
45. Muza S. R., Silverman M. T., Gilmore G. C. et al. Comparison of scales used to quantitate the sense of effort to breathe in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis: 1990; 141 909 913
46. Man W. D., Mustfa N., Nikoletou D. et al. Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD. Thorax: 2004; 59 471 476
47. O'Donnell D. E., Fluge T., Gerken F. et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J: 2004; 23 832 840
48. Chatila W., Nugent T., Vance G. et al. The effects of high-flow vs low-flow oxygen on exercise in advanced obstructive airways disease. Chest: 2004; 126 1108 1115
49. Hunt T., Williams M. T., Frith P. et al. Heliox, dyspnoea and exercise in COPD. Eur Respir Rev: 2010; 19 115 30 38
50. Criner G. J., Belt P., Sternberg A. L. et al. Effects of lung volume reduction surgery on gas exchange and breathing pattern during maximum exercise. Chest: 2009; 135 1268 1279
51. Gigliotti F., Coli C., Bianchi R. et al. Exercise training improves exertional dyspnea in patients with COPD: evidence of the role of mechanical factors. Chest: 2003; 123 1794 1802
52. Koppers R. J., Vos P. J., Boot C. R. et al. Exercise performance improves in patients with COPD due to respiratory muscle endurance training. Chest: 2006; 129 886 892
53. Rubin L. J., Badesch D. B., Barst R. J. et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med: 2002; 346 896 903
54. Grant S., Aitchison T., Henderson E. et al. A comparison of the reproducibility and the sensitivity to change of visual analogue scales, Borg scales, and Likert scales in normal subjects during submaximal exercise. Chest: 1999; 116 1208 1217
55. Dolmage T. E., Hill K., Evans R. A. et al. Has my patient responded? Interpreting clinical measurements such as the 6-minute-walk test. Am J Respir Crit Care Med: 2011; 184 642 646
56. Enright P. L., McBurnie M. A., Bittner V. et al. The 6-min walk test: a quick measure of functional status in elderly adults. Chest: 2003; 123 387 398
57. Camarri B., Eastwood P. R., Cecins N. M. et al. Six minute walk distance in healthy subjects aged 55-75 years. Respir Med: 2006; 100 658 665
58. Huszczuk A., Whipp B. J., Wasserman K. A respiratory gas exchange simulator for routine calibration in metabolic studies. Eur Respir J: 1990; 3 465 468
59. Oudiz R. J., Barst R. J., Hansen J. E. et al. Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension. Am J Cardiol: 2006; 97 123 126
60. ATS ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med: 2002; 166 111 117
61. Turner S. E., Eastwood P. R., Cecins N. M. et al. Physiologic responses to incremental and self-paced exercise in COPD: a comparison of three tests. Chest: 2004; 126 766 773
62. Revill S. M., Morgan M. D., Singh S. J. et al. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax: 1999; 54 213 222
63. Brown C. D., Benditt J. O., Sciurba F. C. et al. Exercise testing in severe emphysema: association with quality of life and lung function. COPD: 2008; 5 117 124
64. Pepin V., Brodeur J., Lacasse Y. et al. Six-minute walking versus shuttle walking: responsiveness to bronchodilation in chronic obstructive pulmonary disease. Thorax: 2007; 62 291 298
65. Wise R. A., Brown C. D. Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test. COPD: 2005; 2 125 129
66. Enright P. L., Sherrill D. L. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med: 1998; 158 1384 1387
67. Gibbons W. J., Fruchter N., Sloan S. et al. Reference values for a multiple repetition 6-minute walk test in healthy adults older than 20 years. J Cardiopulm Rehabil: 2001; 21 87 93
68. Sciurba F., Criner G. J., Lee S. M. et al. Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med: 2003; 167 1522 1527
69. Hernandes N. A., Wouters E. F., Meijer K. et al. Reproducibility of 6-minute walking test in patients with COPD. Eur Respir J: 2011; 38 261 267
70. Demers C., McKelvie R. S., Negassa A. et al. Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure. Am Heart J: 2001; 142 698 703
71. Olsson L. G., Swedberg K., Clark A. L. et al. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J: 2005; 26 778 793
72. Miyamoto S., Nagaya N., Satoh T. et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med: 2000; 161 487 492
73. Reesink H. J., van der Plas M. N., Verhey N. E. et al. Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg: 2007; 133 510 516
74. Modrykamien A. M., Gudavalli R., McCarthy K. et al. Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis. Respir Care: 2010; 55 584 588
75. Lee W. T., Peacock A. J., Johnson M. K. The role of per cent predicted 6-min walk distance in pulmonary arterial hypertension. Eur Respir J: 2010; 36 1294 1301
76. Reichenberger F., Voswinckel R., Enke B. et al. Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension. Eur Respir J: 2007; 30 922 927
77. Piazza G., Goldhaber S. Z. Chronic thromboembolic pulmonary hypertension. N Engl J Med: 2011; 364 351 360
78. Piepoli M. F. Exercise tolerance measurements in pulmonary vascular diseases and chronic heart failure. Respiration: 2009; 77 241 251
79. Baughman R. P., Sparkman B. K., Lower E. E. Six-minute walk test and health status assessment in sarcoidosis. Chest: 2007; 132 207 213
80. Flaherty K. R., Andrei A. C., Murray S. et al. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med: 2006; 174 803 809
81. Villalba W. O., Sampaio-Barros P. D., Pereira M. C. et al. Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients. Chest: 2007; 131 217 222
82. Cardoso F., Tufanin A. T., Colucci M. et al. Replacement of the 6-min walk test with maximal oxygen consumption in the BODE Index applied to patients with COPD: an equivalency study. Chest: 2007; 132 477 482
83. Vogelmeier C., Buhl R., Criee C. P. et al. [Guidelines for the diagnosis and therapy of COPD issued by Deutsche Atemwegsliga and Deutsche Gesellschaft fur Pneumologie und Beatmungsmedizin]. Pneumologie: 2007; 61 e1 e40
84. Celli B. R., MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J: 2004; 23 932 946
85. Casas A., Vilaro J., Rabinovich R. et al. Encouraged 6-min walking test indicates maximum sustainable exercise in COPD patients. Chest: 2005; 128 55 61
86. Redelmeier D. A., Bayoumi A. M., Goldstein R. S. et al. Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med: 1997; 155 1278 1282
87. Make B., Casaburi R., Leidy N. K. Interpreting results from clinical trials: understanding minimal clinically important differences in COPD outcomes. COPD: 2005; 2 1 5
88. Puhan M. A., Chandra D., Mosenifar Z. et al. The minimal important difference of exercise tests in severe COPD. Eur Respir J: 2011; 37 784 790
89. du Bois R. M., Weycker D., Albera C. et al. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am J Respir Crit Care Med: 2011; 183 1231 1237
90. O'Keeffe S. T., Lye M., Donnellan C. et al. Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients. Heart: 1998; 80 377 382
91. Gilbert C., Brown M. C., Cappelleri J. C. et al. Estimating a minimally important difference in pulmonary arterial hypertension following treatment with sildenafil. Chest: 2009; 135 137 142
92. Swigris J. J., Wamboldt F. S., Behr J. et al. The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference. Thorax: 2010; 65 173 177
93. Lettieri C. J., Nathan S. D., Browning R. F. et al. The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis. Respir Med: 2006; 100 1734 1741
94. Swigris J. J., Swick J., Wamboldt F. S. et al. Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosis. Chest: 2009; 136 841 848
95. Palange P., Carlone S., Forte S. et al. Cardiopulmonary exercise testing in the evaluation of patients with ventilatory vs circulatory causes of reduced exercise tolerance. Chest: 1994; 105 1122 1126
96. Kroidl R. F., Schwarz S., Lehnigk B. Kursbuch Spiroergometrie. 2. ed. Stuttgart Thieme: 2009
97. Binder R. K., Wonisch M., Corra U. et al. Methodological approach to the first and second lactate threshold in incremental cardiopulmonary exercise testing. Eur J Cardiovasc Prev Rehabil: 2008; 15 726 734
98. Wasserman K., Whipp B. J., Koyl S. N. et al. Anaerobic threshold and respiratory gas exchange during exercise. J Appl Physiol: 1973; 35 236 243
99. Wasserman K., Whipp B. J., Davis J. A. Respiratory physiology of exercise: metabolism, gas exchange, and ventilatory control. Int Rev Physiol: 1981; 23 149 211
100. Hofmann P., Pokan R., von Duvillard S. P. et al. Heart rate performance curve during incremental cycle ergometer exercise in healthy young male subjects. Med Sci Sports Exerc: 1997; 29 762 768
101. Jones N. L., Makrides L., Hitchcock C. et al. Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis: 1985; 131 700 708
102. Hansen J. E., Sue D. Y., Wasserman K. Predicted values for clinical exercise testing. Am Rev Respir Dis: 1984; 129 49 S55
103. American College of Sports Medicine ACSM's Metabolic Calculations Handbook. Baltimore Lippincott Williams and Wilkins: 2006
104. Rühle K. H. Praxisleitfaden der Spiroergometrie. 2. ed. Stuttgart Kohlhammer: 2009
105. Cooper B., Storer W. Exercise testing and interpretation. Cambridge University Press: 2001
106. Froehlicher V. F., Myers J., Follanbee W. P. et al. Exercise and the heart. St. Louis Mosby: 1993
107. Koulouris N. G., Hardavella G. Physiological techniques for detecting expiratory flow limitation during tidal breathing. Eur Respir Rev: 2011; 20 147 155
108. Johnson B. D., Weisman I. M., Zeballos R. J. et al. Emerging concepts in the evaluation of ventilatory limitation during exercise: the exercise tidal flow-volume loop. Chest: 1999; 116 488 503
109. Pepin V., Saey D., Laviolette L. et al. Exercise capacity in chronic obstructive pulmonary disease: mechanisms of limitation. COPD: 2007; 4 195 204
110. O'Donnell D. E., Banzett R. B., Carrieri-Kohlman V. et al. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc: 2007; 4 145 168
111. Revill S. M., Morgan M. D. Biological quality control for exercise testing. Thorax: 2000; 55 63 66
112. Jones N. L. Clinical exercise testing. 4. ed. Saunders: 1997
113. Wilmore J. H., Stanforth P. R., Turley K. R. et al. Reproducibility of cardiovascular, respiratory, and metabolic responses to submaximal exercise: the HERITAGE Family Study. Med Sci Sports Exerc: 1998; 30 259 265
114. Roca J., Whipp B. J. Clinical exercise testing. 2. ed. European Respiratory Society: 1997
115. Wasserman K., Hansen J. E., Sue D. Y. et al. Principles of exercise testing and interpretation. 4th ed. Philadelphia Lea & Febiger: 2004
116. Schmid A., Schilter D., Fengels I. et al. Design and validation of an interpretative strategy for cardiopulmonary exercise tests. Respirology: 2007; 12 916 923
117. Eschenbacher W. L., Mannina A. An algorithm for the interpretation of cardiopulmonary exercise tests. Chest: 1990; 97 263 267
118. Killian K. J., Leblanc P., Martin D. H. et al. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis: 1992; 146 935 940
119. Cotes J. E., Zejda J., King B. Lung function impairment as a guide to exercise limitation in work-related lung disorders. Am Rev Respir Dis: 1988; 137 1089 1093
120. O'Donnell D. E. Breathlessness in patients with chronic airflow limitation. Mechanisms and management. Chest: 1994; 106 904 912
121. O'Donnell D. E., D'Arsigny C., Fitzpatrick M. et al. Exercise hypercapnia in advanced chronic obstructive pulmonary disease: the role of lung hyperinflation. Am J Respir Crit Care Med: 2002; 166 663 668
122. Spiro S. G., Hahn H. L., Edwards R. H. et al. An analysis of the physiological strain of submaximal exercise in patients with chronic obstructive bronchitis. Thorax: 1975; 30 415 425
123. Lee Y. C., Singh B., Pang S. C. et al. Radiographic (ILO) readings predict arterial oxygen desaturation during exercise in subjects with asbestosis. Occup Environ Med: 2003; 60 201 206
124. Lama V. N., Martinez F. J. Resting and exercise physiology in interstitial lung diseases. Clin Chest Med: 2004; 25 435 53, v
125. Glaser S., Noga O., Koch B. et al. Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Respir Med: 2009; 103 317 324
126. Bush A., Busst C. M. Cardiovascular function at rest and on exercise in patients with cryptogenic fibrosing alveolitis. Thorax: 1988; 43 276 283
127. Spiro S. G., Dowdeswell I. R., Clark T. J. An analysis of submaximal exercise responses in patients with sarcoidosis and fibrosing alveolitis. Br J Dis Chest: 1981; 75 169 180
128. Weitzenblum E., Ehrhart M., Rasaholinjanahary J. et al. Pulmonary hemodynamics in idiopathic pulmonary fibrosis and other interstitial pulmonary diseases. Respiration: 1983; 44 118 127
129. Gibbons W. J., Levy R. D., Nava S. et al. Subclinical cardiac dysfunction in sarcoidosis. Chest: 1991; 100 44 50
130. Lainchbury J. G., Richards A. M. Exercise testing in the assessment of chronic congestive heart failure. Heart: 2002; 88 538 543
131. Arena R., Myers J., Abella J. et al. The ventilatory classification system effectively predicts hospitalization in patients with heart failure. J Cardiopulm Rehabil Prev: 2008; 28 195 198
132. Agostoni P., Pellegrino R., Conca C. et al. Exercise hyperpnea in chronic heart failure: relationships to lung stiffness and expiratory flow limitation. J Appl Physiol: 2002; 92 1409 1416
133. Leite J. J., Mansur A. J., de Freitas H. F. et al. Periodic breathing during incremental exercise predicts mortality in patients with chronic heart failure evaluated for cardiac transplantation. J Am Coll Cardiol: 2003; 41 2175 2181
134. Wensel R., Opitz C. F., Anker S. D. et al. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation: 2002; 106 319 324
135. Janicki J. S., Weber K. T., Likoff M. J. et al. Exercise testing to evaluate patients with pulmonary vascular disease. Am Rev Respir Dis: 1984; 129 93 S95
136. Sun X. G., Hansen J. E., Oudiz R. J. et al. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation: 2001; 104 429 435
137. Vonbank K., Funk G. C., Marzluf B. et al. Abnormal pulmonary arterial pressure limits exercise capacity in patients with COPD. Wien Klin Wochenschr: 2008; 120 749 755
138. Holverda S., Bogaard H. J., Groepenhoff H. et al. Cardiopulmonary exercise test characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension. Respiration: 2008; 76 160 167
139. Pynnaert C., Lamotte M., Naeije R. Aerobic exercise capacity in COPD patients with and without pulmonary hypertension. Respir Med: 2010; 104 121 126
140. Scheidl S. J., Englisch C., Kovacs G. et al. Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients. Eur Respir J: 2012; 39 119 124
141. Sun X. G., Hansen J. E., Oudiz R. J. et al. Gas exchange detection of exercise-induced right-to-left shunt in patients with primary pulmonary hypertension. Circulation: 2002; 105 54 60
142. Stringer W. W., Hansen J. E., Wasserman K. Cardiac output estimated noninvasively from oxygen uptake during exercise. J Appl Physiol: 1997; 82 908 912
143. Ting H., Sun X. G., Chuang M. L. et al. A noninvasive assessment of pulmonary perfusion abnormality in patients with primary pulmonary hypertension. Chest: 2001; 119 824 832
144. Yasunobu Y., Oudiz R. J., Sun X. G. et al. End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest: 2005; 127 1637 1646
145. Dumitrescu D., Oudiz R. J., Karpouzas G. et al. Developing pulmonary vasculopathy in systemic sclerosis, detected with non-invasive cardiopulmonary exercise testing. PLoS One: 2010; 5 e14293
146. Sicari R., Nihoyannopoulos P., Evangelista A. et al. Stress Echocardiography Expert Consensus Statement - Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur Heart J: 2009; 30 278 289
147. Pellikka P. A., Nagueh S. F., Elhendy A. A. et al. American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr: 2007; 20 1021 1041
148. Grunig E., Weissmann S., Ehlken N. et al. Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia. Circulation: 2009; 119 1747 1757
149. Ha J. W., Choi D., Park S. et al. Determinants of exercise-induced pulmonary hypertension in patients with normal left ventricular ejection fraction. Heart: 2009; 95 490 494
150. Lau E. M., Manes A., Celermajer D. S. et al. Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward. Eur Heart J: 2011; 32 2489 2498
151. Grunig E., Barner A., Bell M. et al. [Non-invasive diagnosis of pulmonary hypertension: ESC/ERS Guidelines with commentary of the Cologne Consensus Conference 2010]. Dtsch Med Wochenschr: 2010; 135 67 S77
152. McLaughlin V. V., Archer S. L., Badesch D. B. et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc. 2009; 53 1573 1619
153. Bonow R. O., Carabello B. A., Kanu C. et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation: 2006; 114 e84 e231
154. Eagle K. A., Berger P. B., Calkins H. et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation: 2002; 105 1257 1267
155. Poldermans D., Bax J. J., Boersma E. et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J: 2009; 30 2769 2812
156. Beattie W. S., Abdelnaem E., Wijeysundera D. N. et al. A meta-analytic comparison of preoperative stress echocardiography and nuclear scintigraphy imaging. Anesth Analg: 2006; 102 8 16
157. Kontos M. C., Akosah K. O., Brath L. K. et al. Cardiac complications in noncardiac surgery: value of dobutamine stress echocardiography versus dipyridamole thallium imaging. J Cardiothorac Vasc Anesth: 1996; 10 329 335
158. Wijeysundera D. N., Beattie W. S., Austin P. C. et al. Non-invasive cardiac stress testing before elective major non-cardiac surgery: population based cohort study. BMJ: 2010; 340 b5526
159. Bach D. S., Eagle K. A. Dobutamine stress echocardiography. Stressing the indications for preoperative testing. Circulation: 1997; 95 8 10
160. Jaroszewski D. E., Huh J., Chu D. et al. Utility of detailed preoperative cardiac testing and incidence of post-thoracotomy myocardial infarction. J Thorac Cardiovasc Surg: 2008; 135 648 655
161. Agricola E., Picano E., Oppizzi M. et al. Assessment of stress-induced pulmonary interstitial edema by chest ultrasound during exercise echocardiography and its correlation with left ventricular function. J Am Soc Echocardiogr: 2006; 19 457 463
162. Chan A. K., Govindarajan G., Del Rosario M. L. et al. Dobutamine stress echocardiography Doppler estimation of cardiac diastolic function: a simultaneous catheterization correlation study. Echocardiography: 2011; 28 442 447
163. Yildirim A., Sedef T. F., Pinarli F. G. et al. Early diagnosis of anthracycline toxicity in asymptomatic long-term survivors: dobutamine stress echocardiography and tissue Doppler velocities in normal and abnormal myocardial wall motion. Eur J Echocardiogr: 2010; 11 814 822
164. Herth F., Schulz M. R., Manegold C. et al. [Usefulness of stress echocardiography for early diagnosis of anthracycline-induced cardiomyopathy]. Pneumologie: 2001; 55 385 389
165. Casaburi R., ZuWallack R. Pulmonary rehabilitation for management of chronic obstructive pulmonary disease. N Engl J Med: 2009; 360 1329 1335
166. Huiart L., Ernst P., Suissa S. Cardiovascular morbidity and mortality in COPD. Chest: 2005; 128 2640 2646
167. Meyer-Erkelenz J. D., Mosges R. W., Sieverts H. [Spiroergometry (cardiopulmonary function under load). Report of the results of the 1979 colloquium in Aachen]. Prax Klin Pneumol: 1980; 34 585 600
168. Ozcan C., Zaret B. L. Dobutamine stress test and beta-agonist - a potential concern for nuclear cardiology testing: a case report. Cases J: 2009; 2 7466
169. Olschewski H., Hoeper M. M., Borst M. M. et al. [Diagnosis and therapy of chronic pulmonary hypertension]. Pneumologie: 2006; 60 749 771
170. Agostoni P., Doria E., Galli C. et al. Nifedipine reduces pulmonary pressure and vascular tone during short- but not long-term treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis: 1989; 139 120 125
171. Seibold H., Bunjes D., Schmidt A. et al. Pathophysiological aspects of predominant preload lowering on pulmonary circulation, gas exchange, and the biventricular function in patients with chronic obstructive lung disease. Clin Cardiol: 1988; 11 630 638
172. Blumberg F. C., Riegger G. A., Pfeifer M. Hemodynamic effects of aerosolized iloprost in pulmonary hypertension at rest and during exercise. Chest: 2002; 121 1566 1571
173. Provencher S., Herve P., Sitbon O. et al. Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension. Eur Respir J: 2008; 32 393 398
174. Kovacs G., Berghold A., Scheidl S. et al. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J: 2009; 34 888 894
175. Badesch D. B., Champion H. C., Sanchez M. A. et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol: 2009; 54 S55 S66
176. Opitz C. F. Invasive diagnostic evaluation in patients with pulmonary hypertension. Dtsch Med Wochenschr: 2010; 135 S78 S86
177. Rosenkranz S., Behr J., Ewert R. et al. [Right heart catheterization in pulmonary hypertension]. Dtsch Med Wochenschr: 2011; 136 2601 2616
178. Kovacs G., Maier R., Aberer E. et al. Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma. Am J Respir Crit Care Med: 2009; 180 881 886
179. Steen V., Chou M., Shanmugam V. et al. Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis. Chest: 2008; 134 146 151
180. Tolle J. J., Waxman A. B., Van Horn T. L. et al. Exercise-induced pulmonary arterial hypertension. Circulation: 2008; 118 2183 2189
181. Kovacs G., Maier R., Aberer E. et al. Pulmonary arterial hypertension therapy may be safe and effective in patients with systemic sclerosis and borderline pulmonary artery pressure. Arthritis Rheum: 2012; 64 1257 1262
182. Bonderman D., Martischnig A. M., Vonbank K. et al. Right ventricular load at exercise is a cause of persistent exercise limitation in patients with normal resting pulmonary vascular resistance after pulmonary endarterectomy. Chest: 2011; 139 122 127
183. Minai O. A., Chaouat A., Adnot S. Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective. Chest: 2010; 137 39S 51S
184. Hemnes A. R., Forfia P. R., Champion H. C. Assessment of pulmonary vasculature and right heart by invasive haemodynamics and echocardiography. Int J Clin Pract Suppl: 2009; 4 19
185. Blanco I., Gimeno E., Munoz P. A. et al. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am J Respir Crit Care Med: 2010; 181 270 278
186. Syyed R., Reeves J. T., Welsh D. et al. The relationship between the components of pulmonary artery pressure remains constant under all conditions in both health and disease. Chest: 2008; 133 633 639
187. Carlsen K. H., Anderson S. D., Bjermer L. et al. Treatment of exercise-induced asthma, respiratory and allergic disorders in sports and the relationship to doping: Part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA(2)LEN. Allergy: 2008; 63 492 505
188. Criee C. P., Berdel D., Heise D. et al. [Recommendations on spirometry by Deutsche Atemwegsliga]. Pneumologie: 2006; 60 576 584
189. Deutsche Atemwegsliga und Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin Empfehlungen zur Ganzkörperplethysmographie (Bodyplethysmographie). Dustri Verlag: 2009
190. Joos G. F., O'Connor B., Anderson S. D. et al. Indirect airway challenges. Eur Respir J: 2003; 21 1050 1068
191. Lindemann H., Leupold W. Lungenfunktionsdiagnostik bei Kindern. Kohlhammer: 2003
192. Tancredi G., Quattrucci S., Scalercio F. et al. 3-min step test and treadmill exercise for evaluating exercise-induced asthma. Eur Respir J: 2004; 23 569 574
193. Carlsen K. H. The breathless adolescent asthmatic athlete. Eur Respir J: 2011; 38 713 720
194. Worth H., Meyer A., Folgering H. et al. [Recommendations of the German Respiratory League on sports and physical training for patients with obstructive respiratory tract diseases]. Pneumologie: 2000; 54 61 67
195. Tetzlaff K., Klingmann C., Muth C. M. et al. Checkliste Tauchtauglichkeit. Stuttgart Gentner: 2009
196. Balady G. J., Berra K. A., Golding L. A. et al. Exercise prescription for cardiac patients. In: Frankling B. A., Whaley M. H., Howley E. T. editors ACSMs Guidelines for Exercise Testing and Prescription. Philadelphia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo Lippincott, Williams & Wilkins: 2000; 165 169
197. Stilgenbauer F., Reißnecker S., Steinacker J. M. Herzfrequenzvorgaben für Ausdauertraining von Herzpatienten. Dtsch Z Sportmed: 2003; 53 228 229
198. Carvalho V. O., Mezzani A. Aerobic exercise training intensity in patients with chronic heart failure: principles of assessment and prescription. Eur J Cardiovasc Prev Rehabil: 2011; 18 5 14
199. Simmons D. N., Berry M. J., Hayes S. I. et al. The relationship between HRpeak and VO2peak in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc: 2000; 32 881 886
200. Berry M. J., Woodard C. M. Chronic obstructive pulmonary disease. In: Ehrmann J. K., Gordon P. M., Visich P. S. et al., editors Clinical Exercise Physiology. Human Kinetics: 2003; 3339 3366
201. Beauchamp M. K., Nonoyama M., Goldstein R. S. et al. Interval versus continuous training in individuals with chronic obstructive pulmonary disease - a systematic review. Thorax: 2010; 65 157 164
202. Meyer T., Lucia A., Earnest C. P. et al. A conceptual framework for performance diagnosis and training prescription from submaximal gas exchange parameters - theory and application. Int J Sports Med: 2005; 26 38 S48
203. Friedmann-Bette B. Die Spiroergometrie in der sportmedizinischen Leistungsdiagnostik. Deutsch Z Sportmed: 2011; 62 10 15
204. Friedmann-Bette B. Leistungsdiagnostik und Trainingssteuerung. Therapeutische Umschau: 1998; 55 246 250
205. Deutsche Gesetzliche Unfallversicherung Berufsgenossenschaftliche Grundsätze für arbeitsmedizinische Vorsorgeuntersuchungen. 5. ed. Stuttgart Gentner: 2010
206. Reiterer W. Methodik eines rektangulär-triangulären Belastungstestes. Herz-Kreislauf: 1975; 7 457 462
207. Preisser A. M., Ochmann U. [Cardiopulmonary exercise testing in occupational medical fitness examination and assessment]. Pneumologie: 2011; 65 662 670
208. Preisser A., Baur X. [Proposals for updating of the "Reichenhaller leafleto"- Review of recommendations for occupational diseases in Nrn. 1315 (without alveolitis), 4301 and 4302 layout of BKVo"]. Pneumologie: 2008; 62 491 493
209. Brutsche M. H., Spiliopoulos A., Bolliger C. T. et al. Exercise capacity and extent of resection as predictors of surgical risk in lung cancer. Eur Respir J: 2000; 15 828 832
210. Win T., Jackson A., Sharples L. et al. Cardiopulmonary exercise tests and lung cancer surgical outcome. Chest: 2005; 127 1159 1165
211. Loewen G. M., Watson D., Kohman L. et al. Preoperative exercise Vo2 measurement for lung resection candidates: results of Cancer and Leukemia Group B Protocol 9238. J Thorac Oncol: 2007; 2 619 625
212. Benzo R., Kelley G. A., Recchi L. et al. Complications of lung resection and exercise capacity: a meta-analysis. Respir Med: 2007; 101 1790 1797
213. Brunelli A., Belardinelli R., Refai M. et al. Peak oxygen consumption during cardiopulmonary exercise test improves risk stratification in candidates to major lung resection. Chest: 2009; 135 1260 1267
214. Holden D. A., Rice T. W., Stelmach K. et al. Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection. Chest: 1992; 102 1774 1779
215. Markos J., Mullan B. P., Hillman D. R. et al. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis: 1989; 139 902 910
216. Pierce R. J., Copland J. M., Sharpe K. et al. Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortality. Am J Respir Crit Care Med: 1994; 150 947 955
217. Brunelli A., Refai M., Xiume F. et al. Performance at symptom-limited stair-climbing test is associated with increased cardiopulmonary complications, mortality, and costs after major lung resection. Ann Thorac Surg: 2008; 86 240 247
218. Koegelenberg C. F., Diacon A. H., Irani S. et al. Stair climbing in the functional assessment of lung resection candidates. Respiration: 2008; 75 374 379
219. Goeckenjan G., Sitter H., Thomas M. et al. Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie: 2011; 65 39 59
220. BTS BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax: 2001; 56 89 108
221. Colice G. L., Shafazand S., Griffin J. P. et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest: 2007; 132 161S 177S
222. Brunelli A., Charloux A., Bolliger C. T. et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J: 2009; 34 17 41
223. Choong C. K., Meyers B. F., Battafarano R. J. et al. Lung cancer resection combined with lung volume reduction in patients with severe emphysema. J Thorac Cardiovasc Surg: 2004; 127 1323 1331
224. Older P., Smith R., Courtney P. et al. Preoperative evaluation of cardiac failure and ischemia in elderly patients by cardiopulmonary exercise testing. Chest: 1993; 104 701 704
225. Snowden C. P., Prentis J. M., Anderson H. L. et al. Submaximal cardiopulmonary exercise testing predicts complications and hospital length of stay in patients undergoing major elective surgery. Ann Surg: 2010; 251 535 541
226. Fleisher L. A., Beckman J. A., Brown K. A. et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation: 2007; 116 e418 e499
227. O'Donnell D. E., Voduc N., Fitzpatrick M. et al. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J: 2004; 24 86 94
228. O'Donnell D. E., Fluge T., Gerken F. et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J: 2004; 23 832 840
229. Maltais F., Hamilton A., Marciniuk D. et al. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest: 2005; 128 1168 1178
230. Emtner M., Porszasz J., Burns M. et al. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med: 2003; 168 1034 1042
231. Palange P., Valli G., Onorati P. et al. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. J Appl Physiol: 2004; 97 1637 1642
232. Schonhofer B., Dellweg D., Suchi S. et al. Exercise endurance before and after long-term noninvasive ventilation in patients with chronic respiratory failure. Respiration: 2008; 75 296 303
233. Ferguson G. T., Fernandez E., Zamora M. R. et al. Improved exercise performance following lung volume reduction surgery for emphysema. Am J Respir Crit Care Med: 1998; 157 1195 1203
234. Hopkinson N. S., Toma T. P., Hansell D. M. et al. Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am J Respir Crit Care Med: 2005; 171 453 460
235. Come C. E., Divo M. J., San Jose E. R. et al. Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial. Respir Med: 2012; 106 109 119
236. Sciurba F. C., Ernst A., Herth F. J. et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med: 2010; 363 1233 1244
237. Slebos D. J., Klooster K., Ernst A. et al. Bronchoscopic Lung Volume Reduction Coil treatment of patients with severe heterogeneous emphysema. Chest: 2011
238. Cote C. G., Pinto-Plata V. M., Marin J. M. et al. The modified BODE index: validation with mortality in COPD. Eur Respir J: 2008; 32 1269 1274
239. Oga T., Nishimura K., Tsukino M. et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med: 2003; 167 544 549
240. Chua R., Keogh A. M., Byth K. et al. Comparison and validation of three measures of quality of life in patients with pulmonary hypertension. Intern Med J: 2006; 36 705 710
241. Barst R. J., Rubin L. J., Long W. A. The Primary Pulmonary Hypertension Study Group et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med: 1996; 334 296 302
242. Snow J. L., Kawut S. M. Surrogate end points in pulmonary arterial hypertension: assessing the response to therapy. Clin Chest Med: 2007; 28 75 89, viii
243. Sitbon O., Humbert M., Nunes H. et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol: 2002; 40 780 788
244. Provencher S., Sitbon O., Humbert M. et al. Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension. Eur Heart J: 2006; 27 589 595
245. Diller G. P., Dimopoulos K., Okonko D. et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation: 2005; 112 828 835
246. Groepenhoff H., Vonk-Noordegraaf A., Boonstra A. et al. Exercise testing to estimate survival in pulmonary hypertension. Med Sci Sports Exerc: 2008; 40 1725 1732
247. Giardini A., Hager A., Lammers A. E. et al. Ventilatory efficiency and aerobic capacity predict event-free survival in adults with atrial repair for complete transposition of the great arteries. J Am Coll Cardiol: 2009; 53 1548 1555
248. Wensel R., Francis D. P., Meyer F. J. et al. Incremental prognostic value of cardiopulmonary exercise testing and resting haemodynamics in pulmonary arterial hypertension. Int J Cardiol: 2012; Apr 9 epub ahead of print
249. Kawut S. M., Horn E. M., Berekashvili K. K. et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol: 2005; 95 199 203
250. Muller J., Christov F., Schreiber C. et al. Exercise capacity, quality of life, and daily activity in the long-term follow-up of patients with univentricular heart and total cavopulmonary connection. Eur Heart J: 2009; 30 2915 2920
251. Trojnarska O., Gwizdala A., Katarzynski S. et al. Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease. Cardiol J: 2009; 16 133 141
252. Opitz C. F., Blindt R., Blumberg F. et al. Pulmonary hypertension: Hemodynamic evaluation. Updated Recommendations of the Cologne Consensus Conference 2011. Int J Cardiol: 2011; 154 13 S19
253. Goldberg D. J., French B., McBride M. G. et al. Impact of oral sildenafil on exercise performance in children and young adults after the fontan operation: a randomized, double-blind, placebo-controlled, crossover trial. Circulation: 2011; 123 1185 1193
254. Giardini A., Balducci A., Specchia S. et al. Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients. Eur Heart J: 2008; 29 1681 1687
255. Wax D., Garofano R., Barst R. J. Effects of long-term infusion of prostacyclin on exercise performance in patients with primary pulmonary hypertension. Chest: 1999; 116 914 920
256. Wensel R., Opitz C. F., Ewert R. et al. Effects of iloprost inhalation on exercise capacity and ventilatory efficiency in patients with primary pulmonary hypertension. Circulation: 2000; 101 2388 2392
257. Affuso F., Palmieri E. A., Di Conza J. Tadalafil improves quality of life and exercise tolerance in idiopathic pulmonary arterial hypertension. Int J Cardiol: 2006; 108 429 431
258. Mikhail G. W., Prasad S. K., Li W. et al. Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects. Eur Heart J: 2004; 25 431 436
259. Gilbert C., Brown M. C., Cappelleri J. C. et al. Estimating a minimally important difference in pulmonary arterial hypertension following treatment with sildenafil. Chest: 2009; 135 137 142
260. Oudiz R. J., Roveran G., Hansen J. E. et al. Effect of sildenafil on ventilatory efficiency and exercise tolerance in pulmonary hypertension. Eur J Heart Fail: 2007; 9 917 921
261. Hoeper M. M., Taha N., Bekjarova A. et al. Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids. Eur Respir J: 2003; 22 330 334
262. Riley M. S., Porszasz J., Engelen M. P. et al. Responses to constant work rate bicycle ergometry exercise in primary pulmonary hypertension: the effect of inhaled nitric oxide. J Am Coll Cardiol: 2000; 36 547 556
263. Nagaya N., Kangawa K. Adrenomedullin in the treatment of pulmonary hypertension. Peptides: 2004; 25 2013 2018
264. Guazzi M., Adam V., Conraads V. et al. EACPR/AHA Joint Scientific Statement. Clinical Accomendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J: 2012; epub September 5
265. Dumitrescu D., Rosenkranz S. Atlas Spiroergometrie und Pulmonale Hypertonie. 1. Aufl. Freiburg Jungbluth: 2011